No black box warning on record for Rystiggo
As of the latest FDA labeling reviewed, Rystiggo (ROZANOLIXIZUMAB) does not carry a black box warning. Standard warnings and precautions still apply — see the full Rystiggo medicine page for the complete safety profile.